A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received ...

In this cohort study of hospital admissions among Medicare patients during the COVID-19 pandemic, greater hospital COVID-19 burden was associated with an increased risk of in-hospital adverse effects ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

Maternal hidradenitis suppurativa was linked to an increased risk for pregnancy complications and long-term adverse outcomes in mothers and children.

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...

In a response to a survey, caregivers of people with spinal muscular atrophy identified the risk of severe adverse events and ...

Dr Graff discusses the differences and similarities in managing adverse events associated with bispecific antibodies in ...

Rate this content's potential impact on patient outcomes Submit Rating Thank you! Please share some more information on the rating you have given Submit Feedback ...

The revelation aired during Vance's interview on Joe Rogan's podcast episode with the potential next vice president.

Cleerly Presents Late-Breaking Research on AI-Enabled Quantitative CT Coronary Assessment for Predicting Major Adverse ...

MannKind (MNKD) announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI, or MNKD-201, for pulmonary fibrotic ...